Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 52 citing articles:

CSF and blood biomarkers for Parkinson's disease
Lucilla Parnetti, Lorenzo Gaetani, Paolo Eusebi, et al.
The Lancet Neurology (2019) Vol. 18, Iss. 6, pp. 573-586
Closed Access | Times Cited: 542
SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration
Danish Idrees, Vijay Kumar
Biochemical and Biophysical Research Communications (2021) Vol. 554, pp. 94-98
Open Access | Times Cited: 136
International consensus statement on allergy and rhinology: Olfaction
Zara M. Patel, Eric H. Holbrook, Justin H. Turner, et al.
International Forum of Allergy & Rhinology (2022) Vol. 12, Iss. 4, pp. 327-680
Open Access | Times Cited: 80
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease
Tracy Cole, Hien Zhao, Timothy J. Collier, et al.
JCI Insight (2021) Vol. 6, Iss. 5
Open Access | Times Cited: 94
Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms
Soheil Mohammadi, Fatemeh Moosaie, Mohammad Hadi Aarabi
Molecular Neurobiology (2020) Vol. 57, Iss. 12, pp. 5263-5275
Open Access | Times Cited: 85
Tau in the Pathophysiology of Parkinson’s Disease
Lina Pan, Lanxia Meng, Mingyang He, et al.
Journal of Molecular Neuroscience (2021) Vol. 71, Iss. 11, pp. 2179-2191
Open Access | Times Cited: 74
Extracellular vesicle biomarkers for cognitive impairment in Parkinson’s disease
Joseph Blommer, Toni L. Pitcher, Maja Mustapić, et al.
Brain (2022) Vol. 146, Iss. 1, pp. 195-208
Open Access | Times Cited: 64
Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
Tracy R. Melzer, Megan Stark, Ross Keenan, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 65
Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration
Mahsa Dolatshahi, Mohammadmahdi Sabahi, Mohammad Hadi Aarabi
Molecular Neurobiology (2021) Vol. 58, Iss. 5, pp. 2379-2394
Open Access | Times Cited: 45
Nanostructured label–free electrochemical immunosensor for detection of a Parkinson's disease biomarker
Pedro Carneiro, Joana A. Loureiro, Cristina Delerue‐Matos, et al.
Talanta (2022) Vol. 252, pp. 123838-123838
Closed Access | Times Cited: 28
The Role of Tau beyond Alzheimer’s Disease: A Narrative Review
Eleonora Virgilio, Fabiola De Marchi, Elena Contaldi, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 760-760
Open Access | Times Cited: 24
Data‐driven disease progression model of Parkinson's disease and effect of sex and genetic variants
Ryota Jin, Hideki Yoshioka, Hiromi Sato, et al.
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 4, pp. 649-659
Open Access | Times Cited: 5
Cerebrospinal fluid biomarker for Parkinson's disease: An overview
Fabian Maass, Isabel Schulz, Paul Lingor, et al.
Molecular and Cellular Neuroscience (2018) Vol. 97, pp. 60-66
Closed Access | Times Cited: 41
Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson's disease
Asya Ozkızılcık, Aruna Sharma, José Vicente Lafuente, et al.
Progress in brain research (2019), pp. e7-e7
Closed Access | Times Cited: 29
Associations of Neuropsychiatric Features with Cerebrospinal Fluid Biomarkers of Amyloidogenesis and Neurodegeneration in Dementia with Lewy Bodies Compared with Alzheimer’s Disease and Cognitively Healthy People
Fabricio Ferreira de Oliveira, Marjorie Câmara Miraldo, Eduardo Ferreira de Castro-Neto, et al.
Journal of Alzheimer s Disease (2021) Vol. 81, Iss. 3, pp. 1295-1309
Closed Access | Times Cited: 23
Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson’s disease
Xiaotong Wang, Huan Yu, Fengtao Liu, et al.
Journal of Neurology (2021) Vol. 269, Iss. 5, pp. 2469-2478
Closed Access | Times Cited: 22
Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
Jaime M. Hatcher-Martin, J. Lucas McKay, Alyssa F. Pybus, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 21
Proteinopathy and Longitudinal Cognitive Decline in Parkinson Disease
Peter S. Myers, John O’Donnell, Joshua J. Jackson, et al.
Neurology (2022) Vol. 99, Iss. 1
Open Access | Times Cited: 15
New markers in Parkinson's disease
Anastasia Bougea
Advances in clinical chemistry (2020), pp. 137-178
Closed Access | Times Cited: 23
Mild traumatic brain injury exacerbates Parkinson's disease induced hemeoxygenase-2 expression and brain pathology: Neuroprotective effects of co-administration of TiO2 nanowired mesenchymal stem cells and cerebrolysin
Aruna Sharma, Dafin F. Mureșanu, Ala Nozari, et al.
Progress in brain research (2020), pp. e5-e6
Closed Access | Times Cited: 23
Tau: a biomarker of Huntington’s disease
Eva Lepinay, Francesca Cicchetti
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4070-4083
Closed Access | Times Cited: 7
Insights into Dysregulated Neurological Biomarkers in Cancer
Elisa Duranti, Chiara Villa
Cancers (2024) Vol. 16, Iss. 15, pp. 2680-2680
Open Access | Times Cited: 2
Mixed Borrelia burgdorferi and Helicobacter pylori Biofilms in Morgellons Disease Dermatological Specimens
Marianne J Middelveen, Katherine R. Filush, Cheryl Bandoski, et al.
Healthcare (2019) Vol. 7, Iss. 2, pp. 70-70
Open Access | Times Cited: 19
Detection and assessment of alpha-synuclein in Parkinson disease
Hsien-Hao Tsao, Chung‐Guei Huang, Yih‐Ru Wu
Neurochemistry International (2022) Vol. 158, pp. 105358-105358
Closed Access | Times Cited: 11
Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure
Farzaneh Ghazi Sherbaf, Bahram Mohajer, Amir Ashraf‐Ganjouei, et al.
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top